Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aurelius Value is an activist short-selling research firm that specializes in forensic financial analysis and investigative reporting on publicly traded companies. The firm is known for publishing critical reports that allege corporate fraud, accounting discrepancies, and misleading disclosures, often leading to significant market reactions. Although it is a financial entity rather than a life sciences company, Aurelius Value has gained prominence in the healthcare sector by targeting biotech and medical device firms, such as MiMedx and Cassava Sciences, with allegations of data manipulation and unethical business practices. Its reports typically involve deep-dive investigations into clinical trial integrity, regulatory compliance, and executive conduct to support its short theses.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aurelius Value.